ArticleBMC medicine2023

The citrate transporter SLC13A5 as a therapeutic target for kidney disease: evidence from Mendelian randomization to inform drug development.

Dipender Gill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.